Common Stock, Value, Issued of Kairos Pharma, LTD. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: Kairos Pharma, LTD. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
Kairos Pharma, LTD. Common Stock, Value, Issued for the quarter ending 30 Sep 2025 was $21,000, a 62% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

Kairos Pharma, LTD. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$21,000	+$8,000	+62%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$18,000			30 Jun 2025	10-Q	12 Aug 2025	2025	Q2
Q1 2025	$16,000			31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$14,000	+$3,000	+27%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$13,000			30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q4 2023	$11,000			31 Dec 2023	10-K	15 Apr 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.